VOYAGER THERAPEUTICS, INC.

Profile

Company Names

VOYAGER THERAPEUTICS, INC.

Addresses

75 HAYDEN AVENUE, LEXINGTON, MA 02421

64 SIDNEY STREET, CAMBRIDGE, MA 02139

75 SIDNEY STREET, CAMBRIDGE, MA 02139

Phone Numbers

857-259-5340

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$119,032,823.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-01-03 
$19,999,999.00 
$19,999,999.00 
$0.00 
Equity 
2
2023-02-23 
$39,032,821.00 
$39,032,821.00 
$0.00 
Equity 
1
2015-04-09 
$60,000,003.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MITCHELL 
S. 
BLOOM 
EXECUTIVE OFFICER
AFFERENT PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  CORIDEA NC1, INC.   |  NAUREX INC.   |  RANA THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  AXON THERAPIES INC.
TODD 
 
CARTER 
EXECUTIVE OFFICER
PANDA POWER GENERATION INFRASTRUCTURE FUND B, L.P.   |  PANDA POWER GENERATION INFRASTRUCTURE FUND A, L.P.   |  PANDA POWER FUND II A, L.P.   |  PANDA POWER FUND II B, L.P.   |  PANDA POWER FUND II FEEDER, L.P.   |  TAGASAURIS, INC.   |  PANDA POWER ANNEX FUND A, L.P.   |  PANDA POWER ANNEX FUND B, L.P.   |  PNFP PROPERTIES, INC   |  VOYAGER THERAPEUTICS, INC.
GRACE 
 
COLON 
DIRECTOR
INTREXON CORP   |  INCARDA THERAPEUTICS, INC.   |  PERCEPTIMED, INC.   |  COCOON BIOTECH INC.   |  PARADIGM DIAGNOSTICS, INC.   |  VOYAGER THERAPEUTICS, INC.
JACQUELYN 
 
FAHEY SANDELL 
EXECUTIVE OFFICER
VOYAGER THERAPEUTICS, INC.
JAMES 
 
GERAGHTY 
DIRECTOR
VOYAGER THERAPEUTICS, INC.   |  IMMUNEXCITE, INC.   |  FULCRUM THERAPEUTICS, INC.   |  PIERIS PHARMACEUTICALS, INC.
JAMES 
A. 
GERAGHTY 
DIRECTOR
GENETIX PHARMACEUTICALS INC   |  ORCHARD THERAPEUTICS PLC   |  VOYAGER THERAPEUTICS, INC.
ROBERT 
W. 
HESSLEIN 
EXECUTIVE OFFICER
FOUNDATION MEDICINE, INC.   |  VOYAGER THERAPEUTICS, INC.
MICHAEL 
 
HIGGINS 
DIRECTOR
STAGE I DIAGNOSTICS, INC.   |  TGD ORLANDO, LLC   |  ARRIA NLG LTD   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  KINDEX PHARMACEUTICALS, INC.   |  GFM HOLDINGS, LLC   |  CAMP4 THERAPEUTICS CORP   |  GENOCEA BIOSCIENCES, INC.   |  NOCION THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.
STEVEN 
 
HYMAN 
DIRECTOR
PRESIDENT + FELLOWS OF HARVARD COLLEGE   |  Q-STATE HOLDINGS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  CYCLERION THERAPEUTICS, INC.
MARK 
 
LEVIN 
DIRECTOR
NINEPOINT MEDICAL, INC.   |  ELEVEN BIOTHERAPEUTICS, INC.   |  CONSTELLATION PHARMACEUTICALS INC   |  FOUNDATION MEDICINE, INC.   |  KARSAMERICA FINANCE LLC   |  DC DEVICES, INC.   |  THIRD ROCK VENTURES III, L.P.   |  ALLSTAR DEALS, INC.   |  MAKI SHOP STORE 1 LLC   |  ROLL-D HOLDINGS, LLC   |  VOYAGER THERAPEUTICS, INC.   |  CORVIA MEDICAL, INC.   |  FULCRUM THERAPEUTICS, INC.   |  MAKI SHOP STORE 3 LLC   |  HIRSHMARK CAPITAL REIT LLC
CATHERINE 
 
MACKEY 
DIRECTOR
GENELUX CORP   |  EVOLVE BIOSYSTEMS, INC.   |  COUR PHARMACEUTICALS DEVELOPMENT CO INC   |  VOYAGER THERAPEUTICS, INC.
JUDE 
 
ONYIA 
DIRECTOR
VOYAGER THERAPEUTICS, INC.
STEVEN 
 
PAUL 
EXECUTIVE OFFICER, DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  SAGE THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  SEAPORT THERAPEUTICS, INC.
PETER 
 
PFREUNDSCHUH 
EXECUTIVE OFFICER
CIRCULITE INC   |  VOYAGER THERAPEUTICS, INC.
GLENN 
 
PIERCE 
DIRECTOR
CACSFF REIT   |  VOYAGER THERAPEUTICS, INC.
ALFRED 
 
SANDROCK 
EXECUTIVE OFFICER, DIRECTOR
PRAXIS PRECISION MEDICINES, INC.   |  VOYAGER THERAPEUTICS, INC.
GEORGE 
 
SCANGOS 
DIRECTOR
DECIBEL THERAPEUTICS, INC.   |  VIR BIOTECHNOLOGY, INC.   |  OCTAVE BIOSCIENCE INC   |  REZO THERAPEUTICS, INC.   |  ENCENTRIO THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.
ROBIN 
 
SWARTZ 
EXECUTIVE OFFICER
VOYAGER THERAPEUTICS, INC.
NANCY 
 
VITALE 
DIRECTOR
VOYAGER THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-01-17
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-01-03 
2023-03-03
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-02-23 
2015-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHESTNUT PARTNERS, INC.
38387